COMPARATIVE STUDY
JOURNAL ARTICLE
RANDOMIZED CONTROLLED TRIAL
Add like
Add dislike
Add to saved papers

A prospective comparison of preperitoneal tension-free open herniorrhaphy with mesh plug herniorrhaphy for the treatment of femoral hernias.

Surgery 2010 November
BACKGROUND: Although many techniques exist for hernia repair, controversy still exists as to the best management of femoral hernias. We compared the preperitoneal approach with the mesh plug technique for the treatment of femoral hernias.

METHODS: In this prospective study, 85 patients with primary unilateral femoral hernias were assigned randomly to a preperitoneal group (n = 45; 10 males, 35 females) and a mesh plug group (n = 40; 10 males, 30 females). Polypropylene patches or plugs were used, and all operations were performed by the same team. Patient demographics, recurrence rate, duration of hospital stay, and complications were recorded. The duration of follow-up ranged from 6 to 78 months.

RESULTS: There were no differences between the groups with respect to operative time, postoperative duration of stay, pain assessed by visual analog scale, or wound infection rate. There were no recurrences in the preperitoneal group, whereas there were 4 (10%) recurrences in the mesh plug group. In the preperitoneal group, no patient complained of a foreign body sensation, whereas in the mesh plug group, 6 patients (15%) had the sensation of a "foreign body" in the groin. In the preperitoneal group, there were 2 cases (4%) of seroma that occurred 3 and 5 days after operation. In the mesh plug group, 8 cases (20%) of seroma occurred 3-7 days after operation.

CONCLUSION: Preperitoneal herniorrhaphy seems to be associated with a lesser recurrence rate, less sensation of a foreign body postoperatively, and a lesser incidence of seroma formation compared with the mesh plug technique in the repair of femoral hernias. Preperitoneal herniorrhaphy provides better vision of the operative field, is flexible, and allows exploration of the inguinal canal during the procedure.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app